Clinical Trial Stage
Objective
CIRM’s Clinical Trial funding program supports the clinical development of stem cell-based and genetic therapy approaches for treatment of diseases with unmet medical needs. Funded projects are expected to have a comprehensive clinical development strategy aimed at attaining marketing approval while ensuring that clinical trial demographics match those of the larger patient population. The clinical development strategy should include stage-appropriate pre-commercialization activities, including planning to ensure that approved treatments are accessible and affordable.
Explore Funding Opportunities
The CLIN2 application period is closed.
Applications for CLIN2 funding will be accepted four times a year, approximately on a quarterly basis. In 2026, Application deadlines are currently planned for the last business day of the month, 2 PM (PT) for January, April, July, and October.
Visit the CLIN2 Awards page on our website for more information about the CLIN2 Awards, including deadlines, requirements, webinar information, and FAQs.
The CLIN2 Awards aim to expedite clinical development toward late-stage trials by promoting innovative trial designs and incentivizing strategies for stage-appropriate market access and pre-commercialization activities.
Download the CLIN2 Program Announcement for more details regarding Award eligibility, review criteria, and Application information.
- CLIN2: Program Announcement [PDF | Updated August 6, 2026]
To Submit an Application
Log in with your existing CIRM username and password. If you do not have a username, click on the New User link and follow the instructions to create a username and password in the GMS. Please note that only the Principal Investigator or their delegate can begin an Application in GMS. CIRM cannot change the PI after the Application has been started. For more information on delegation in GMS, please refer to the Grants Management FAQs.
After logging in, click on the Menu tab. Select the tab labeled Open Programs under the section labeled RFAs and Programs Open for Applications, click on the Start a Grant Application link under Actions for your desired program. If you are associated with multiple institutions in the GMS, you will be prompted to select the institution you are applying under.
Click on the appropriate link and follow the instructions. Proposal templates can be located and submitted under the Uploads section.
Most CIRM Applications require dual submission by the Principal Investigator (PI) and a verified Authorized Organizational Official (AOO) (please refer to the Grants Management FAQs for more information regarding verifying an AOO). Once all the mandatory sections have been completed, a button will appear prompting the Principal Investigator to Submit the Application. Please note that once this has been selected, you will no longer be able to make changes to your Application unless your AOO returns the Application to you. If a secondary AOO approval is required, the Application will appear in the assigned AOO’s GMS account under Action Items Needing Your Attention. The assigned AOO will have the option to either Submit the Application or Return the Application to PI for Revision.
Select the tab labeled Your Applications and check the table under the section labeled Your Submitted Applications. You will see your Application number and project title listed once the submission process has been completed.